June 1st 2018 – The German G-BA has started the procedure for the benefit assessment of Takeda (Tigenix) Alofisel®️ (darvadstrocel). The publication of the benefit assessment is expected on September 3rd and a final resolution end of November 2018.

link to G-BA webpage

 

Previous PostNext Post